---
$id: https://graph.org.ai/products/commodity/51263301
$type: Product
source: UNSPSC
code: "51263301"
title: "Nafetolol"
class: "51263300"
classTitle: "Adrenergic blocking agents, synthesized"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nafetolol

**UNSPSC Code**: 51263301
**Class**: [Adrenergic blocking agents, synthesized](Adrenergic blocking agents, synthesized.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C19H29NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MAL2XF17MP, chemically known as 1,4-ethanonaphthalen-5-ol, 8-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, but generally known as nafetolol, which bears US NIH Compound Identifier 68668. European Medicines Agency schedules Nafetolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09121MIG. The term NAFETOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). NAFETOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nafetolol under HS 29221980 and SITC 51461. As of Q4 2014, NAFETOLOL remains the US FDA Preferred Term for this commodity. Nafetolol bears US NLM identifiers UMLS ID C2983886 and NCI Concept Code C90799. SMILES: O(C1C2C3CCC(CC3)C2C(O)CC1)CC(O)CNC(C)(C)C.

